Filing Details

Accession Number:
0001457612-22-000020
Form Type:
5
Zero Holdings:
No
Publication Time:
2022-03-16 17:31:08
Reporting Period:
2021-12-31
Accepted Time:
2022-03-16 17:31:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1457612 Genocea Biosciences Inc. GNCA Biological Products, (No Disgnostic Substances) (2836) 510596811
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1696784 Diantha Duvall C/O Genocea Biosciences, Inc.
100 Acorn Park Drive, 5Th Floor
Cambridge MA 02140
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-04-02 925 $2.71 62,997 No 4 S Direct
Common Stock Disposition 2021-06-01 511 $2.23 62,486 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person.